Indomethacin-induced intestinal lesions in the rat.
D000284:Administration, Oral; D000818:Animals; D000863:Antacids / Q000494:pharmacology; D001241:Aspirin; D001285:Atropine / Q000494:pharmacology; D001652:Bile Ducts / Q000502:physiology; D001949:Bretylium Compounds / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D002792:Cholestyramine Resin / Q000494:pharmacology; D003533:Cyproheptadine / Q000494:pharmacology; D005508:Food Deprivation; D007213:Indomethacin / Q000008:administration & dosage; D007279:Injections, Subcutaneous; D007410:Intestinal Diseases / Q000139:chemically induced / Q000517:prevention & control; D007412:Intestinal Fistula; D007416:Intestinal Perforation / Q000139:chemically induced*; D007421:Intestine, Small / Q000473:pathology / Q000502:physiology; D008297:Male; D010424:Pentobarbital / Q000494:pharmacology; D010437:Peptic Ulcer / Q000139:chemically induced; D010653:Phenylbutazone; D051381:Rats; D012601:Scopolamine / Q000494:pharmacology; D013217:Starvation; D013997:Time Factors
D000863:Antacids; D001949:Bretylium Compounds; D002792:Cholestyramine Resin; D003533:Cyproheptadine; D001285:Atropine; D012601:Scopolamine; D010653:Phenylbutazone; D010424:Pentobarbital; D001241:Aspirin; D002746:Chlorpromazine; D007213:Indomethacin